CDR2L Antibodies: A New Player in Paraneoplastic Cerebellar Degeneration. e66002
CDR2L Antibodies: A New Player in Paraneoplastic Cerebellar Degeneration. e66002
About this item
Full title
CDR2L Antibodies: A New Player in Paraneoplastic Cerebellar Degeneration. e66002
Author / Creator
Journal title
PloS one, 2013-06, Vol.8 (6)
Language
English
Formats
More information
Scope and Contents
Contents
Objective Yo antibodies are associated with paraneoplastic cerebellar degeneration (PCD). We have characterized Yo sera by measuring CDR2 and CDR2L antibodies and the localization of their antigens. Methods Forty-two Yo sera from patients with paraneoplastic neurological syndromes (PNS), 179 sera from ovarian and 114 sera from breast cancer patient...
Alternative Titles
Full title
CDR2L Antibodies: A New Player in Paraneoplastic Cerebellar Degeneration. e66002
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1412503052
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1412503052
Other Identifiers
E-ISSN
1932-6203
DOI
10.1371/journal.pone.0066002
How to access this item
Log in as a Library member
